AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
BigHat Biosciences closes $75M Series C led by DFJ Growth and Premji Invest to advance AI-driven biotech pipeline.
Amount Raised
$75 Million
Round Type
Series C
San MateoBiotechnologyInvestors
Description
BigHat Biosciences, a California-based clinical-stage AI-driven biotech company, announced the completion of a $75 million Series C financing round. The round was co-led by DFJ Growth and Premji Invest, with participation from Catalio Capital Management, LG Technology Ventures, and Sigmas Group. Existing investors including 8VC, Alexandria Venture Investments, Amgen, Andreessen Horowitz, Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly, Merck Global Health Innovation Fund, Quadrille Capital, and Section 32 also participated. The funding brings BigHat's total capital raised to date to $223 million.
Fundz sees it the moment BigHat Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BigHat Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.